A new analysis found that acute anemia in patients who had a heart attack is associated with a higher risk of death or recurrent myocardial infarction at 30 days.
This phase 3 study demonstrated that roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is noninferior to rHuEPO-α in improving hemoglobin levels for chemotherapy-induced anemia,...
The FDA approves the first-of-its-kind treatment for anemia caused by CKD for adults who receive dialysis following the results of a randomized clinical trial.
Previous evidence regarding this potential association has been conflicting. In a recent study, researchers aimed to clarify this relationship further.
The US Preventive Services Task Force has issued a new draft statement regarding the potential addition of nontraditional risk factors to existing cardiovascular risk assessment models.
Low testosterone is common in men with type 2 diabetes, and prior research has suggested a connection between low testosterone levels and anemia in this population. A recent study presented at the 2017...
